Healthcare >> CEO Interviews >> December 14, 1998

Sam Eletr – Lynx Therapeutics Inc (lynx)

SAM ELETR, Ph.D., is the founding Chairman of the Board and Chief Executive Officer of Lynx Therapeutics, Inc. Lynx was formed in 1992 as a 'spin-off' of Applied Biosystems, Inc. ('ABI'), a manufacturer of instruments and consumables for life science research and related applications. Dr. Eletr co-founded ABI, now a wholly-owned subsidiary of Perkin-Elmer Corporation and served as CEO and Chairman of the Board, and in various other executive positions at ABI from its inception until March 1987. Dr. Eletr acted as a consultant to ABI from September 1990 until July 1992, at which time he undertook to assume the leadership of Lynx. Dr. Eletr received a Master's degree in Physics and a Ph.D. in Physical Chemistry from the University of California at Berkeley. Following post-doctoral research at the CNRS in France and at the University of California School of Medicine in San Francisco, he joined the staff of the Hewlett-Packard Corporate Research Laboratories where he headed a group responsible for the Development of Analytical and Medical Instruments before leaving HP to undertake the formation of ABI. Profile
TWST: Would you give us a quick overview and a little bit of the history

of Lynx just to set the scene for our readers?

Dr. Eletr: Lynx began operations in late 1992. It currently numbers